ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average – Time to Sell?

Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $81.73 and traded as high as $83.21. ProShares Ultra Nasdaq Biotechnology shares last traded at $81.97, with a volume of 6,034 shares.

ProShares Ultra Nasdaq Biotechnology Price Performance

The business’s 50 day moving average price is $81.73 and its 200 day moving average price is $81.64. The stock has a market capitalization of $76.23 million, a P/E ratio of 20.68 and a beta of 1.25.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

A number of large investors have recently made changes to their positions in BIB. Palumbo Wealth Management LLC bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the third quarter worth approximately $766,000. Kaizen Financial Strategies bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the fourth quarter worth approximately $424,000. Citadel Advisors LLC bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the third quarter worth approximately $307,000. Finally, Franklin Resources Inc. bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the second quarter worth approximately $32,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.